Background Non-AIDS-defining cancers (NADCs) are now becoming a rising cause of
morbidity among people living with HIV (PLHIV) in the highly active antiretroviral therapy …

Multiple risk factors are for all types of cancers. These include endogenous factors and
exogenous factors. The main constitutional and environmental risk factors are well clarified …

Despite significant advances in the management of antiretroviral therapy (ART), leading to
improved life expectancy for people living with HIV (PLWH), the incidence of non-AIDS …

Background Mortality among people with human immunodeficiency virus (HIV) declined with
the introduction of combination antiretroviral therapy. We investigated trends in mortality in …

Simple Summary People living with HIV have an increased risk of developing cancer during
their lifetime. Thanks to the introduction and evolution of antiretroviral therapy, cancer …

Abstract Chordin-like 1 (CHRDL1), an inhibitor of bone morphogenetic proteins (BMPs), has
been recently reported to participate in the progression of numerous tumors, however, its …

Background Both AIDS-defining and non-AIDS-defining cancers (ADC/NADC) predispose
people living with HIV (PLHIV) to critical illnesses. The objective of this multicentre study was …

Background The Food and Drug Administration recommends that people living with HIV
(PWH) with a CD4+ T cell count (CD4)≥ 350 cells/µL may be eligible for any cancer clinical …

Despite significant advances in the treatment and care of people with HIV (PWH), several
challenges remain in our understanding of disease pathogenesis to improve patient care …

South Africa has more than 8 million people living with HIV. However, the number of patients
undergoing haematopoietic stem-cell transplantation (HSCT) in South Africa is far below the …